Harvard Bioscience (HBIO) Times Interest Earned (2010 - 2026)
Harvard Bioscience (HBIO) posted quarterly Times Interest Earned of -$0.82 for Q1 2026, up 98.45% year-over-year from -$0.41 in Q1 2025, and up 40.03% quarter-over-quarter from -$1.37 in Q4 2025.
Harvard Bioscience (HBIO) Times Interest Earned (2010 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Times Interest Earned for 17 consecutive years, with -$0.82 the latest figure, recorded in Q1 2026.
- In Q1 2026, Times Interest Earned rose 98.45% year-over-year to -$0.82; the TTM figure through Mar 2026 stood at -$0.06 (up 99.89% YoY), while the FY2025 annual figure was -$2.44, down 599.35% from the prior year.
- Times Interest Earned grew to -$0.82 in Q1 2026 per HBIO's latest filing, from -$1.37 in the prior quarter.
- Across five years, Times Interest Earned topped out at $1.69 in Q2 2022 and bottomed at -$52.89 in Q1 2025.
- Historically, Times Interest Earned has averaged -$3.51 across 5 years, with a median of -$0.46 in 2025.
- Annual changes were most pronounced in 2022 — Times Interest Earned jumped 12401.05% — and 2025, when it plunged 6236.04%.
- Harvard Bioscience's Times Interest Earned stood at $0.34 in 2022, then gained by 5.66% to $0.36 in 2023, then tumbled by 93.76% to $0.02 in 2024, then plunged by 6236.04% to -$1.37 in 2025, then surged by 40.03% to -$0.82 in 2026.
- Business Quant data shows HBIO's Times Interest Earned at -$0.82 in Q1 2026, -$1.37 in Q4 2025, and $0.21 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 5.02 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 0.21 |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 68.88 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -1.48 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Harvard Bioscience | 33.45 Mn | 26.94 Mn | 12.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.11 |
| Mar 31, 2026 | -0.82 |
| Dec 31, 2025 | -1.37 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -52.89 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | -1.27 |
| Jun 30, 2024 | -1.17 |
| Mar 31, 2024 | -2.09 |
| Dec 31, 2023 | 0.36 |
| Sep 30, 2023 | -0.70 |
| Jun 30, 2023 | 0.35 |
| Mar 31, 2023 | 1.30 |
| Dec 31, 2022 | 0.34 |
| Sep 30, 2022 | -0.36 |
| Jun 30, 2022 | 1.69 |
| Mar 31, 2022 | -2.83 |
| Dec 31, 2021 | -2.15 |
| Sep 30, 2021 | 0.04 |